alendronate has been researched along with mastoparan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
A Alfaleh, M; Al-Hejaili, OD; Aldawsari, HM; Aldhabi, BM; Alhakamy, NA; Alqarni, HM; Alselami, MO; Alshehri, S; Badr-Eldin, SM; Bakhaidar, RB; F Alghaith, A; H Abdulaal, W; Mahdi, WA; Okbazghi, SZ; Zahrani, MA | 1 |
1 other study(ies) available for alendronate and mastoparan
Article | Year |
---|---|
Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells.
Topics: A549 Cells; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Caspase 3; Cell Cycle; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Nanoconjugates; Particle Size; Wasp Venoms | 2022 |